ReviewOncoTargets and therapy2021

Clinical Evaluation of Ramucirumab for the Treatment of Hepatocellular Carcinoma (HCC): Place in Therapy.

Khalil Choucair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.